{"id":"https://openalex.org/W7011513680","doi":null,"title":"Mechanisms of Antihypertensive Actions of Angiotensin-Converting Enzyme-2 (ACE2)","display_name":"Mechanisms of Antihypertensive Actions of Angiotensin-Converting Enzyme-2 (ACE2)","alternate_titles":[],"publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W7011513680"},"language":"en","primary_location":{"id":"pmh:oai:nsuworks.nova.edu:faculty_research_grant_winners-1424","doi":null,"is_oa":false,"landing_page_url":"https://nsuworks.nova.edu/faculty_research_grant_winners/317","pdf_url":null,"source":{"id":"https://openalex.org/S4377196410","display_name":"NSUWorks (Nova Southeastern University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I203088144","host_organization_name":"Nova Southeastern University","host_organization_lineage":["https://openalex.org/I203088144"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"President's Research Grant","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W7011513680"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025905944","display_name":"Robert Charles Speth","orcid":"https://orcid.org/0000-0002-6434-2136","observed_orcids":["https://orcid.org/0000-0002-6434-2136"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Speth, Robert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Zimmerman, Max","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zimmerman, Max","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Choi, Benedict","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Choi, Benedict","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiotensin-converting-enzyme-2","display_name":"angiotensin-converting enzyme 2","score":0.9549999833106995},{"id":"https://openalex.org/keywords/neurogenic-hypertension","display_name":"neurogenic hypertension","score":0.7699999809265137},{"id":"https://openalex.org/keywords/angiotensin-ii","display_name":"angiotensin II","score":0.8659999966621399},{"id":"https://openalex.org/keywords/angiotensin-1-7","display_name":"angiotensin-(1-7)","score":0.9959999918937683},{"id":"https://openalex.org/keywords/mas-receptor","display_name":"Mas receptor","score":0.8149999976158142},{"id":"https://openalex.org/keywords/angiotensin-ii-type-1-receptor","display_name":"angiotensin II type 1 receptor","score":0.9959999918937683},{"id":"https://openalex.org/keywords/angiotensin-ii-type-2-receptor","display_name":"angiotensin II type 2 receptor","score":0.9779999852180481},{"id":"https://openalex.org/keywords/nucleus-tractus-solitarius","display_name":"nucleus tractus solitarius","score":0.9459999799728394},{"id":"https://openalex.org/keywords/rostral-ventrolateral-medulla","display_name":"rostral ventrolateral medulla","score":0.9879999756813049},{"id":"https://openalex.org/keywords/blood-pressure-regulation","display_name":"blood pressure regulation","score":0.9229999780654907},{"id":"https://openalex.org/keywords/antihypertensive-mechanism","display_name":"antihypertensive mechanism","score":0.8769999742507935}],"concepts":[{"id":"https://openalex.org/C123915805","wikidata":"https://www.wikidata.org/wiki/Q15332826","display_name":"Angiotensin II receptor type 1","level":4,"score":0.9065999984741211},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.8331999778747559},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.7240999937057495},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5928999781608582},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.5807999968528748},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5685999989509583},{"id":"https://openalex.org/C104849204","wikidata":"https://www.wikidata.org/wiki/Q24778533","display_name":"Angiotensin receptor","level":4,"score":0.45089998841285706},{"id":"https://openalex.org/C75184817","wikidata":"https://www.wikidata.org/wiki/Q5381540","display_name":"Enzyme-linked receptor","level":3,"score":0.4499000012874603},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36890000104904175},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3398999869823456},{"id":"https://openalex.org/C116016267","wikidata":"https://www.wikidata.org/wiki/Q18039826","display_name":"Interleukin-21 receptor","level":3,"score":0.3264999985694885},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3091000020503998},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.30889999866485596},{"id":"https://openalex.org/C17971392","wikidata":"https://www.wikidata.org/wiki/Q18027445","display_name":"5-HT5A receptor","level":3,"score":0.3077000081539154},{"id":"https://openalex.org/C125268873","wikidata":"https://www.wikidata.org/wiki/Q17918484","display_name":"Protease-activated receptor 2","level":4,"score":0.2994000017642975},{"id":"https://openalex.org/C2778110749","wikidata":"https://www.wikidata.org/wiki/Q189033","display_name":"Medulla oblongata","level":3,"score":0.29100000858306885},{"id":"https://openalex.org/C135285700","wikidata":"https://www.wikidata.org/wiki/Q38173","display_name":"G protein-coupled receptor","level":3,"score":0.2646999955177307},{"id":"https://openalex.org/C2993002077","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Receptor expression","level":3,"score":0.26089999079704285},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2597000002861023},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2554999887943268},{"id":"https://openalex.org/C56191518","wikidata":"https://www.wikidata.org/wiki/Q416997","display_name":"Peptide hormone","level":3,"score":0.2493000030517578},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24040000140666962},{"id":"https://openalex.org/C2780838160","wikidata":"https://www.wikidata.org/wiki/Q2447639","display_name":"Solitary tract","level":3,"score":0.2280000001192093},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.1907999962568283},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.1868000030517578},{"id":"https://openalex.org/C2779395532","wikidata":"https://www.wikidata.org/wiki/Q7916469","display_name":"Vascular smooth muscle","level":3,"score":0.1860000044107437},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.18539999425411224},{"id":"https://openalex.org/C149577978","wikidata":"https://www.wikidata.org/wiki/Q24777577","display_name":"Protease-activated receptor","level":4,"score":0.1826999932527542},{"id":"https://openalex.org/C26702167","wikidata":"https://www.wikidata.org/wiki/Q901988","display_name":"Metabotropic receptor","level":4,"score":0.18050000071525574},{"id":"https://openalex.org/C197462201","wikidata":"https://www.wikidata.org/wiki/Q2476074","display_name":"Cell surface receptor","level":3,"score":0.1768999993801117},{"id":"https://openalex.org/C66135807","wikidata":"https://www.wikidata.org/wiki/Q24726231","display_name":"Gq alpha subunit","level":4,"score":0.1754000037908554},{"id":"https://openalex.org/C33114225","wikidata":"https://www.wikidata.org/wiki/Q7370060","display_name":"Rostral ventrolateral medulla","level":4,"score":0.17509999871253967},{"id":"https://openalex.org/C201729690","wikidata":"https://www.wikidata.org/wiki/Q5401841","display_name":"Estrogen-related receptor alpha","level":5,"score":0.17479999363422394},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.17419999837875366},{"id":"https://openalex.org/C2777670902","wikidata":"https://www.wikidata.org/wiki/Q492038","display_name":"Human brain","level":2,"score":0.17350000143051147},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.17139999568462372},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.16930000483989716},{"id":"https://openalex.org/C172773627","wikidata":"https://www.wikidata.org/wiki/Q753583","display_name":"5-HT1 receptor","level":5,"score":0.16920000314712524},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.1688999980688095},{"id":"https://openalex.org/C103474210","wikidata":"https://www.wikidata.org/wiki/Q142851","display_name":"Immune receptor","level":3,"score":0.1679999977350235}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:nsuworks.nova.edu:faculty_research_grant_winners-1424","doi":null,"is_oa":false,"landing_page_url":"https://nsuworks.nova.edu/faculty_research_grant_winners/317","pdf_url":null,"source":{"id":"https://openalex.org/S4377196410","display_name":"NSUWorks (Nova Southeastern University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I203088144","host_organization_name":"Nova Southeastern University","host_organization_lineage":["https://openalex.org/I203088144"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"President's Research Grant","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2164449616","https://openalex.org/W1964696346","https://openalex.org/W3175822425","https://openalex.org/W2119013194","https://openalex.org/W2262529701","https://openalex.org/W1980058856","https://openalex.org/W3173781720","https://openalex.org/W2096677035"],"abstract_inverted_index":{"This":[0],"study":[1,263],"examines":[2],"the":[3,12,32,56,69,91,94,111,133,146,150,175,183,195,203,216,243,247,271],"mechanisms":[4],"whereby":[5],"overexpression":[6,144],"of":[7,21,76,93,135,158,218,242,261,269,281],"angiotensin-converting":[8],"enzyme-2":[9],"(ACE2)":[10],"in":[11,17,80,90,110,132,168,202,228],"brain":[13,99,118,230,272],"lowers":[14],"blood":[15,66,103,122,274],"pressure":[16,67,104,123,275],"a":[18,26,40,98,222,266],"mouse":[19],"model":[20],"neurogenic":[22],"hypertension.":[23],"ACE2":[24,81,143],"is":[25,55,68,127],"recently":[27],"discovered":[28],"enzyme":[29],"that":[30,52,64,85,174,239],"converts":[31],"pressor":[33],"hormone":[34],"angiotensin":[35,43],"II":[36,51,137,225,250],"(Ang":[37,45],"II)":[38],"into":[39],"depressor":[41],"hormone,":[42],"1-7":[44,63,140],"1-7).":[46],"The":[47,59,259],"receptor":[48,60,160,166,170,177,193,208,233,245,257],"for":[49,61,102,121,152],"Ang":[50,62,136,139,224,249],"causes":[53],"hypertension":[54],"AT1":[57,77,86,159,165,169,176,184,192,200,244,256],"subtype.":[58],"reduces":[65],"Mas":[70,107],"oncogene":[71],"protein":[72,227,252],"(Mas).":[73],"Immunohistochemical":[74],"studies":[75,197,213],"and":[78,113,138,205,221,246],"Mas-immunoreactivity":[79],"overexpressing":[82],"mice":[83,172],"suggests":[84],"receptors":[87,151,201,220,236],"are":[88],"decreased":[89],"nucleus":[92],"solitary":[95],"tract":[96],"(NTS,":[97],"region":[100,119],"important":[101],"homeostasis)":[105],"while":[106],"was":[108],"increased":[109],"NTS":[112,204],"rostroventrolateral":[114],"medulla":[115],"(RVLM,":[116],"another":[117],"critical":[120],"regulation).":[124],"However,":[125],"it":[126],"not":[128],"known":[129],"how":[130,270],"alterations":[131],"levels":[134],"caused":[141],"by":[142,149,232],"affects":[145],"signaling":[147],"mediated":[148],"these":[153,188,212,229],"angiotensins.":[154],"Moreover,":[155],"Western":[156],"blots":[157],"immunoreactivity":[161,167],"show":[162],"bands":[163],"with":[164],"knock-out":[171],"suggesting":[173],"antibodies":[178],"recognize":[179],"protein(s)":[180],"other":[181],"than":[182],"receptor.":[185],"To":[186],"resolve":[187],"questions":[189],"about":[190],"altered":[191],"functionality":[194],"proposed":[196],"will":[198,214,264],"measure":[199],"RVLM":[206],"using":[207],"autoradiography.":[209,234],"In":[210],"addition,":[211],"examine":[215],"expression":[217],"AT2":[219,235],"novel":[223,248],"binding":[226,251],"regions":[231],"have":[237],"actions":[238],"oppose":[240],"those":[241],"may":[253,277],"also":[254],"counteract":[255],"effects.":[258],"findings":[260],"this":[262],"provide":[265],"better":[267],"understanding":[268],"controls":[273],"which":[276],"lead":[278],"to":[279],"development":[280],"improved":[282],"antihypertensive":[283],"drugs.":[284]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7011513680","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2025-10-10T00:00:00"}
